SES AI Corporation

Background

Company Name	SES AI Corporation
Stock Symbol	SES
Class Period	January 29, 2025 to March 04, 2026
Lead Plaintiff Motion Deadline	June 26, 2026

Submit Your Information

If you suffered a loss on your SES AI Corporation investments or would like to inquire about joining an action to recover your loss under the federal securities laws, please complete the form below. Please note that submission of this form does not by itself form an attorney-client relationship nor does filling out this form mean you have joined any lawsuit.

First Name*

Middle Initial

Last Name*

Email*

Phone*

If representing a Corporation, Trust, Partnership or other entity, Name of Entity

If representing an Entity, Position at Entity

Mailing Address

City

State/Province

ZIP/Postal Code

Country

Are you a current or former employee of the company?

Did you purchase any shares before January 29, 2025?

Shares Purchased

Number of Shares	Buy Date	Price Per Share	Add
Purchased quantity	Purchased month Purchased day Purchased year

Shares Sold

Number of Shares	Sell Date	Price Per Share	Add
	Sold month Sold day Sold year

Additional Comments

Background

On December 9, 2025, Wolfpack Research published a report alleging, among other things, that SES AI “promoted an AI product (“Molecular Universe”) that looks . . . like a Chat GPT wrapper to distract from its impending loss of two major customers, Honda and Hyundai, at the end of 2025” and that “[t]o replace this massive hold in their income statement, SES has purchased UZ Energy, a Chinese Energy Storage System (ESS) provider” which “appears to have little American presence.”

Then, on March 4, 2026, SES AI released its fourth quarter and full year 2025 financial results, announcing 2026 revenue guidance below market expectations.

On this news, SES AI’s stock price fell $0.63, or 36.8%, to close at $1.08 per share on March 5, 2026, thereby injuring investors.

The complaint filed in this class action alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company’s business, operations, and prospects. Specifically, Defendants failed to disclose to investors that: (1) SES AI overstated its business prospects by materially overstating the expected results that could be achieved by deals with companies that have limited or no operations; (2) SES AI created an appearance of revenue by purchasing services in exchange for purchases of Molecular Universe; (3) Contrary to its positive statements regarding growth prospects, SES AI was affected by material logistics constraints in the fourth quarter of 2025 which would materially affect Q4 2025 revenues; (4) the foregoing called into question SES AI’s growth prospects for 2026, which were confirmed due to lower-than expected 2026 revenue guidance; and (5) as a result, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis at all relevant times.

Submit Your Information